- Korea Drug Development Fund for Development of novel anti-cancer drug targeting p34, a novel modulator of NEDD4-1-mediated PTEN ubiquitination
- Approval of the antiplatelet Adinox
2015.
The establishment of Pharmaceutical Laboratory
2014.
- Conducted the Technological Innovation R&D Program funded by the Small and Medium Business Administration(SMBA, Korea)
- Conducted the Industry-Academia-Research Institute Cooperation Cluster Support Program funded by Ministry of Science, ICT and Future Planning
2013.
Conducted joint research for the development of cancer metastasis inhibitors supervised by the Ministry of Education and Science Technology
2012.
The expansion and relocation of the Chodang Research Center from Ansan to Seoul
2009.
Signed new product introducing contracts with foreign multinational corporations and conducted joint research with venture businesses for the development of innovative dosage form
2008.
Conducted joint research with pharmacy colleges of national universities for the development of innovative dosage form
2005.
Conducted national projects (3 years) with the Ministry of Health and Welfare on “the development of new systems for oriental medicine for the treatment of chronic conditions in children”
2004.
The acquisition of approval for Korea’s first garlic drug “the Alican Capsule”
2001.
The patent registration of 3 counts of “neutral hair-dyeing agent compositions”
현재 결제가 진행중입니다.
본 결제 창은 결제완료 후 자동으로 닫히며,결제 진행 중에 본 결제 창을 닫으시면
주문이 되지 않으니 결제 완료 될 때 까지 닫지 마시기 바랍니다.
WORLD SHIPPING
PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :
